Log In
Print
BCIQ
Print
Print this Print this
 

DCVax-Brain (DCVax-L)

  Manage Alerts
Collapse Summary General Information
Company Northwest Biotherapeutics Inc.
DescriptionAutologous dendritic cells treated ex vivo with glioblastoma tumor fragments
Molecular Target Not applicable
Mechanism of ActionImmune modulation
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase III
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma multiforme (GBM); Treat malignant gliomas; Treat newly diagnosed glioblastoma multiforme (GBM)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today